Psychosocial Development of Maltreated Children: A Prospective Study
NCT ID: NCT02148419
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
17 participants
OBSERVATIONAL
2014-02-28
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The HRQoL and mental health of children will be impaired following maltreatment even while controlling for others possible predictors of impaired HRQoL and mental health.
* We assume a dose-response relationship between severity of maltreatment and impaired HRQoL. Multiple maltreatment is hypothesized to have a larger impact then a single type of maltreatment.
* At baseline, HRQoL scores are hypothesized to be at a markedly low level. We assume a slight increase in HRQoL from baseline to first follow-up, but not a continuing increase to second follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Child-Parent Psychotherapy - a Feasibility Study for Children in Foster Care
NCT04519229
Facing Adverse Childhood Experiences
NCT05122988
Reduce Childhood Maltreatment and Promote Development
NCT03031236
Disseminating Child Abuse Clinical Decision Support to Improve Detection, Evaluation and Reporting
NCT03840798
A Pilot Intervention With Families of Children With Special Health Care Needs
NCT02742831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The HRQoL and mental health of children will be impaired following maltreatment even while controlling for others possible predictors of impaired HRQoL and mental health.
* We assume a dose-response relationship between severity of maltreatment and impaired HRQoL. Multiple maltreatment is hypothesized to have a larger impact then a single type of maltreatment.
* At baseline, HRQoL scores are hypothesized to be at a markedly low level. We assume a slight increase in HRQoL from baseline to first follow-up, but not a continuing increase to second follow-up.
* We assume differing trends for outcome variables in the aftermath of maltreatment and intend to analyze if types of trends are associated with clusters of risk and protective factors (cf. Chaffin, Bard, Hecht, \& Silovsky, 2011).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatients
* Sexual abuse
* Physical maltreatment
* Psychological maltreatment
* Neglect
* Substantiated maltreatment
* Indicated maltreatment
* Aged 0-15 years at recruitment
Exclusion Criteria
* Munchausen Syndrome by proxy
* Maltreatment not confirmed
* Aged 16 years and older at recruitment
1 Day
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Baden
OTHER
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Jud,PhD
Dr. Andreas Jud
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Jud, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Children's Hospital, Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Children's Hospital
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2013-0331
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.